Off‑the‑shelf, engineered non-living stem cell strategy for advancing cellular therapies - Nature
A customizable strategy for lyophilized, tannic acid-engineered non-living cells enables on-demand manufacture of non-living stem cell formulations for diverse diseases, including ulcerative colitis, hindlimb ischaemia and asthma.